• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TEOXANE SA TEOSYAL RHA 3; PATIENT RESTRAINT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TEOXANE SA TEOSYAL RHA 3; PATIENT RESTRAINT Back to Search Results
Model Number NOT APPLICABLE
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Angioedema (4536)
Event Date 02/23/2022
Event Type  Injury  
Event Description
According to the information received on 24-feb-2022, a patient was injected on (b)(6) 2022 with a rha 3 product, 0.3ml, to the lips.Later that evening, the patient woke up from a nap, took a picture and sent it to the injector.From looking at the picture, the injector diagnosed an angioedema.The patient met at the hospital with the injector and was prescribed corticoids and antihistaminic.It was unknown if the diagnosis of angioedema was confirmed at the hospital.The patient was recovering from the event.
 
Event Description
According to the information received on 24-feb-2022, a patient was injected on (b)(6) 2022 with a rha 3 product, 0.3ml, to the lips.Later that evening, the patient woke up from a nap, took a picture and sent it to the injector.From looking at the picture, the injector diagnosed an angioedema.The patient met at the hospital with the injector and was immediately treated with intravenous benadryl and 25mg decadron, and oral steroids for two days.It was unknown if the diagnosis of angioedema was confirmed at the hospital.The patient was recovering from the event.Final: on 12-apr-2022, we were informed that the patient fully recovered from the event.The corrective treatments were also added.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TEOSYAL RHA 3
Type of Device
PATIENT RESTRAINT
Manufacturer (Section D)
TEOXANE SA
rue de lyon
105
geneva 1203
CH  1203
Manufacturer (Section G)
TEOXANE SA
rue de lyon
105
geneva 1203
CH   1203
Manufacturer Contact
nicolas caill
rue de lyon
105
geneva 1203
CH   1203
022344-963
MDR Report Key13860640
MDR Text Key287686960
Report Number3005975625-2022-00100
Device Sequence Number1
Product Code LMH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P170002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 05/24/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNOT APPLICABLE
Device Catalogue NumberNOT APPLICABLE
Device Lot Number212518A0
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received03/23/2022
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received05/24/2022
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient SexFemale
Patient RaceWhite
-
-